FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282927550> ?p ?o ?g. }

• W4282927550 endingPage "3820" @default.
• W4282927550 startingPage "3820" @default.
• W4282927550 abstract "Abstract The recent development of genome-wide spatial transcriptomics (ST) approaches enable near single-cell gene expression profiling to infer cellular composition and intercellular interactions that drive cancer development and responses to therapy. This study applied ST on 10 surgical biospecimens from a clinical trial with neoadjuvant therapy with cabozantinib (multi-kinase inhibitor) and nivolumab (anti-PD-1 monoclonal antibody) with advanced hepatocellular carcinoma (HCC). Within our cohort, 6 of the samples were obtained from non-responders and 4 with demonstrated pathological response were previously associated with immune infiltration using spatial proteomics technologies. Our analysis with ST was performed to determine the specific pathways that drive immune infiltration in responders and to map intercellular interactions relevant for response and resistance to the combined therapy.Analysis of these data uncovered three main differences between responders and non-responders. First, to better understand the tumor mechanisms of response and resistance, we performed differential expression and pathway analysis only in the subset of tumor clusters from responders versus non-responders. In responders, we observed enrichment for pathways associated with immune response (TNF-alpha, IFN-gamma, T cell differentiation), while in non-responders the deregulated pathways are associated with cell growth, transcriptional activity and hypoxia (Myc, E2F, oxidative phosphorylation). Second, the intercellular interaction analyses indicate that CD8-HLA interactions are more abundant in responders, while interactions activating VEGFR, the main target of cabozantinib, are enriched in non-responders. The interaction profiles are evidence that in responders the tumor cells express tumor specific antigens that are recognized by the cytotoxic cells which activity is enhanced by nivolumab. In non-responders, the activation of the VEGF pathway is an indication that the tumor cells have developed mechanism of resistance to cabozantinib. Third, responding tumors have higher densities of immune and stromal cells, and the immune cells are enriched with aggregates composed of both B and T cells. The regions surrounded by these immune aggregates are transcriptionally distinct from regions enriched for stromal cells, suggesting that tumor gene expression profile drives immune infiltration.Overall, the ST analysis of neoadjuvant HCC treated samples detects tumor induced immune cell immune infiltration in responders compared to non-responders with enrichment of cytotoxic interactions to eliminate the tumor cells. It also identifies intercellular interactions suggestive of resistance to anti-VEGF blockade. Citation Format: Luciane T. Kagohara, Shuming Zhang, Long Yuan, Qingfeng Zhu, Robert Anders, Daniel Shu, Aleksander S. Popel, Elizabeth M. Jaffee, Mark Yarchoan, Elana J. Fertig. Spatial transcriptomics of advanced hepatocellular carcinomas distinguishes intercellular interactions in responders and non-responders to cabozantinib and nivolumab neoadjuvant therapy [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 3820." @default.
• W4282927550 created "2022-06-16" @default.
• W4282927550 creator A5008314164 @default.
• W4282927550 creator A5020240160 @default.
• W4282927550 creator A5027701541 @default.
• W4282927550 creator A5050642902 @default.
• W4282927550 creator A5069901102 @default.
• W4282927550 creator A5076456783 @default.
• W4282927550 creator A5079942940 @default.
• W4282927550 creator A5083237199 @default.
• W4282927550 creator A5091367936 @default.
• W4282927550 creator A5091745216 @default.
• W4282927550 date "2022-06-15" @default.
• W4282927550 modified "2023-10-07" @default.
• W4282927550 title "Abstract 3820: Spatial transcriptomics of advanced hepatocellular carcinomas distinguishes intercellular interactions in responders and non-responders to cabozantinib and nivolumab neoadjuvant therapy" @default.
• W4282927550 doi "https://doi.org/10.1158/1538-7445.am2022-3820" @default.
• W4282927550 hasPublicationYear "2022" @default.
• W4282927550 type Work @default.
• W4282927550 citedByCount "0" @default.
• W4282927550 crossrefType "journal-article" @default.
• W4282927550 hasAuthorship W4282927550A5008314164 @default.
• W4282927550 hasAuthorship W4282927550A5020240160 @default.
• W4282927550 hasAuthorship W4282927550A5027701541 @default.
• W4282927550 hasAuthorship W4282927550A5050642902 @default.
• W4282927550 hasAuthorship W4282927550A5069901102 @default.
• W4282927550 hasAuthorship W4282927550A5076456783 @default.
• W4282927550 hasAuthorship W4282927550A5079942940 @default.
• W4282927550 hasAuthorship W4282927550A5083237199 @default.
• W4282927550 hasAuthorship W4282927550A5091367936 @default.
• W4282927550 hasAuthorship W4282927550A5091745216 @default.
• W4282927550 hasConcept C104317684 @default.
• W4282927550 hasConcept C121608353 @default.
• W4282927550 hasConcept C126322002 @default.
• W4282927550 hasConcept C143998085 @default.
• W4282927550 hasConcept C150194340 @default.
• W4282927550 hasConcept C154317977 @default.
• W4282927550 hasConcept C162317418 @default.
• W4282927550 hasConcept C202751555 @default.
• W4282927550 hasConcept C203014093 @default.
• W4282927550 hasConcept C2777701055 @default.
• W4282927550 hasConcept C2778019345 @default.
• W4282927550 hasConcept C2778695046 @default.
• W4282927550 hasConcept C2780030458 @default.
• W4282927550 hasConcept C2781064419 @default.
• W4282927550 hasConcept C2781230642 @default.
• W4282927550 hasConcept C502942594 @default.
• W4282927550 hasConcept C55493867 @default.
• W4282927550 hasConcept C71924100 @default.
• W4282927550 hasConcept C86803240 @default.
• W4282927550 hasConcept C8891405 @default.
• W4282927550 hasConceptScore W4282927550C104317684 @default.
• W4282927550 hasConceptScore W4282927550C121608353 @default.
• W4282927550 hasConceptScore W4282927550C126322002 @default.
• W4282927550 hasConceptScore W4282927550C143998085 @default.
• W4282927550 hasConceptScore W4282927550C150194340 @default.
• W4282927550 hasConceptScore W4282927550C154317977 @default.
• W4282927550 hasConceptScore W4282927550C162317418 @default.
• W4282927550 hasConceptScore W4282927550C202751555 @default.
• W4282927550 hasConceptScore W4282927550C203014093 @default.
• W4282927550 hasConceptScore W4282927550C2777701055 @default.
• W4282927550 hasConceptScore W4282927550C2778019345 @default.
• W4282927550 hasConceptScore W4282927550C2778695046 @default.
• W4282927550 hasConceptScore W4282927550C2780030458 @default.
• W4282927550 hasConceptScore W4282927550C2781064419 @default.
• W4282927550 hasConceptScore W4282927550C2781230642 @default.
• W4282927550 hasConceptScore W4282927550C502942594 @default.
• W4282927550 hasConceptScore W4282927550C55493867 @default.
• W4282927550 hasConceptScore W4282927550C71924100 @default.
• W4282927550 hasConceptScore W4282927550C86803240 @default.
• W4282927550 hasConceptScore W4282927550C8891405 @default.
• W4282927550 hasIssue "12_Supplement" @default.
• W4282927550 hasLocation W42829275501 @default.
• W4282927550 hasOpenAccess W4282927550 @default.
• W4282927550 hasPrimaryLocation W42829275501 @default.
• W4282927550 hasRelatedWork W2559335392 @default.
• W4282927550 hasRelatedWork W2792841998 @default.
• W4282927550 hasRelatedWork W2943049136 @default.
• W4282927550 hasRelatedWork W3109577649 @default.
• W4282927550 hasRelatedWork W3169998899 @default.
• W4282927550 hasRelatedWork W4247159264 @default.
• W4282927550 hasRelatedWork W4283513043 @default.
• W4282927550 hasRelatedWork W4384946498 @default.
• W4282927550 hasRelatedWork W4385477321 @default.
• W4282927550 hasRelatedWork W849272724 @default.
• W4282927550 hasVolume "82" @default.
• W4282927550 isParatext "false" @default.
• W4282927550 isRetracted "false" @default.
• W4282927550 workType "article" @default.